Table 2

Descriptive table of 12-month patient outcomes stratified by SBP levels (N=12 337)

SBP≤105(1)105<SBP≤115(2)115<SBP≤130(3)130<SBP≤140(4)SBP>140(5)TotalP value*
Total (%)3.610.334.927.423.7100
SBP measurements
Mean (SD)2.39 (1.92)2.90 (2.01)3.19 (2.23)3.22 (2.28)3.15 (2.00)3.14 (2.16)<0.001†
Outcomes
Recurrent ischaemic stroke/TIA22 (7.7)66 (6.3)236 (5.6)214 (6.2)212 (6.4)750 (6.1)0.438
Cardiovascular events‡5 (1.7)15 (1.4)83 (2.0)72 (2.1)58 (1.8)233 (6.1)0.671
Total vascular events§24 (8.4)80 (7.7)304 (7.2)275 (8.0)260 (7.8)943 (7.7)0.732
All-cause mortality28 (9.8)38 (3.7)143 (3.4)98 (2.8)123 (3.7)430 (3.5)<0.001
  • *P values from χ2 or one-way ANOVA.

  • †Significant contrasts from one-way ANOVA (Scheffe test, p<0.05): (1) less than (2–5); (2) greater than (1); (3) greater than (1, 2); (4) greater than (1, 2) and (5) greater than (1, 2).

  • ‡Cardiovascular Events: myocardial infarction/acute coronary syndrome, ventricular arrhythmias.

  • §Total Vascular Events: recurrent stroke/TIA, myocardial infarction/acute coronary syndrome, ventricular arrhythmias.

  • ANOVA, analysis of variance; SBP, systolic blood pressure; TIA, transient ischaemic attack.